IL2 and amyotrophic lateral sclerosis: Interestingly, to a certain extent, compared to 2MIU IL2 group, 1MIU IL2 group, a lower dose of IL2 therapy, might be beneficial for survival time of ALS patients in the long-term (about 64 days).